Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH

ClinicalTrials.gov ID: NCT07335601

Public ClinicalTrials.gov record NCT07335601. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 20, 2026, 4:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate MGL-3196 (Resmetirom) in Patients With MASH Who Have Undergone Liver Transplant for MASH Cirrhosis or Other Etiologies

Study identification

NCT ID: NCT07335601
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Madrigal Pharmaceuticals, Inc.; Industry
Enrollment: 120 participants

Conditions and interventions

Conditions

MASH - Metabolic Dysfunction-Associated Steatohepatitis

Interventions

Placebo Drug
Resmetirom Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 75 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 28, 2025
Primary completion: Jun 30, 2027
Completion: Nov 30, 2027
Last update posted: Apr 29, 2026

2025 – 2027

United States locations

U.S. sites: 14
U.S. states: 9
U.S. cities: 13

Facility	City	State	ZIP	Site status
University of California San Diego	La Jolla	California	92037	Not yet recruiting
University of California Los Angeles Medical Center	Los Angeles	California	90095	Not yet recruiting
University of California, San Francisco	San Francisco	California	94143	Not yet recruiting
University of Colorado	Aurora	Colorado	80045	Not yet recruiting
Northwestern University	Chicago	Illinois	60208	Recruiting
The University of Chicago Medicine	Chicago	Illinois	60637	Not yet recruiting
Mayo Clinic	Rochester	Minnesota	55905	Not yet recruiting
Northwell Health Inc, Center for Liver Disease and Transplantation	Manhasset	New York	11030	Not yet recruiting
New York Presbyterian Hospital	New York	New York	10065	Not yet recruiting
Vanderbilt University Medical Center (VUMC)	Nashville	Tennessee	37212	Not yet recruiting
Dallas Methodist	Dallas	Texas	75203	Not yet recruiting
Houston Methodist Hospital	Houston	Texas	77030	Not yet recruiting
Intermountain Medical Center	Murray	Utah	84107	Not yet recruiting
University of Virginia Health System	Charlottesville	Virginia	22903	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07335601, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 29, 2026 · Synced May 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07335601 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →